FTSE 100 today: BoE rate decision looms; Vodafone names CFO; Whitbread reports

European markets declined Thursday, with the FTSE 100 down 0.4% ahead of the Bank of England's rate decision, as several UK companies released updates; Vodafone appointed a Microsoft executive as CFO effective October 2025, while Frasers Group abandoned its bid for Revolution Beauty, causing a 21% drop in Revolution Beauty's shares. Whitbread reported weak UK performance offset by growth in Germany, and Hays Plc anticipates £45 million in profit amid a global hiring slowdown, while XPS Pensions reported strong full-year results, exceeding EBITDA forecasts with an 18% rise in annual revenue.

Analysis

European equity markets, including the UK's FTSE 100 which fell 0.4%, commenced Thursday's session with declines, reflecting investor caution ahead of the Bank of England's interest rate decision, where no change is broadly anticipated; the British pound also weakened 0.2% against the dollar. In corporate developments, Vodafone announced the appointment of Microsoft executive Pilar López as its next Chief Financial Officer, effective October 1, 2025, a forward-looking leadership change. Conversely, Frasers Group's decision to abandon its pursuit of Revolution Beauty triggered a significant adverse reaction, with Revolution Beauty shares plummeting over 21%, while Frasers Group itself experienced a 1.5% share price decline. Whitbread reported a mixed first-quarter performance for fiscal 2026; robust growth in its German operations helped to mitigate weaker UK results, where Premier Inn saw a 2% year-on-year fall in total accommodation revenue and a 3% dip in like-for-like sales, alongside limited forward visibility due to prevailing economic and geopolitical uncertainties. The recruitment sector shows signs of strain, as Hays Plc anticipates a pre-exceptional operating profit of £45 million for fiscal 2025, citing a persistent slowdown in global permanent recruitment markets and subdued fourth-quarter activity. In stark contrast, XPS Pensions Group delivered strong full-year results, with an 18% increase in annual revenue to £231.8 million and a 27% surge in adjusted EBITDA to £69.7 million, surpassing market forecasts and expanding its EBITDA margin by 2.2 percentage points to 30.1%. Separately, Eli Lilly announced its intention to appeal a UK agency's recommendation against reimbursing its Alzheimer’s drug, Kisunla.

Key Decisions for Investors

• Investors should closely monitor the Bank of England's impending rate decision and subsequent commentary for potential impacts on UK market sentiment and sterling, given the prevailing cautious open.
• The significant share price drop in Revolution Beauty following Frasers Group's withdrawal warrants caution; assess its standalone viability and recovery prospects before considering any exposure.
• XPS Pensions Group's robust earnings and margin improvement suggest strong fundamentals, potentially offering a more resilient investment compared to cyclical firms like Hays, which is signaling caution due to macroeconomic headwinds.
• For Whitbread, investors should weigh the positive momentum in its German operations against the softness in its core UK market and stated limited forward visibility when evaluating its outlook.
• Vodafone's CFO appointment, though effective in late 2025, may be a long-term positive for strategic financial management; however, immediate stock impact is likely to be muted.